Nektar Therapeutics (NKTR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 242.38M |
| Enterprise Value | 56.54M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.78 |
| Price/Book (mrq) | 1.85 |
| Enterprise Value/Revenue | 0.63 |
| Enterprise Value/EBITDA | -0.23 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.91 |
| 52-Week Change 3 | 51.72% |
| S&P500 52-Week Change 3 | 21.23% |
| 52 Week High 3 | 1.7500 |
| 52 Week Low 3 | 0.4100 |
| 50-Day Moving Average 3 | 0.9446 |
| 200-Day Moving Average 3 | 0.6632 |
Share Statistics
| Avg Vol (3 month) 3 | 2.43M |
| Avg Vol (10 day) 3 | 4.44M |
| Shares Outstanding 5 | 183.62M |
| Implied Shares Outstanding 6 | 183.62M |
| Float 8 | 163.11M |
| % Held by Insiders 1 | 0.82% |
| % Held by Institutions 1 | 67.25% |
| Shares Short (Mar 28, 2024) 4 | 2.36M |
| Short Ratio (Mar 28, 2024) 4 | 0.96 |
| Short % of Float (Mar 28, 2024) 4 | 2.75% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 1.28% |
| Shares Short (prior month Feb 29, 2024) 4 | 2.01M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Aug 23, 2000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -128.37% |
Management Effectiveness
| Return on Assets (ttm) | -15.25% |
| Return on Equity (ttm) | -110.95% |
Income Statement
| Revenue (ttm) | 90.12M |
| Revenue Per Share (ttm) | 0.47 |
| Quarterly Revenue Growth (yoy) | 8.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -127.41M |
| Net Income Avi to Common (ttm) | -276.06M |
| Diluted EPS (ttm) | -1.4500 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 303.62M |
| Total Cash Per Share (mrq) | 1.65 |
| Total Debt (mrq) | 230.4M |
| Total Debt/Equity (mrq) | 175.90% |
| Current Ratio (mrq) | 6.45 |
| Book Value Per Share (mrq) | 0.68 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -192.61M |
| Levered Free Cash Flow (ttm) | -63.63M |
© 2024 Yahoo. All rights reserved.